Most bought healthcare stocks in Q3 2021
See which Healthcare stocks institutional investors increased the most in Q3 2021, measured as net growth in reported share positions from Q2 2021 into Q3 2021. Notable additions at the top of this list include SANOFI-ADR (SNY), WARBY PARKER INC-CLASS A (WRBY), GILEAD SCIENCES INC (GILD), QUANTUM-SI INC (QSI). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| SNY | SANOFI-ADR | 23,792,525 | $831.13K | 0 | 2 | 1 | 1 | 4 |
| WRBY | WARBY PARKER INC-CLASS A | 23,020,206 | $1.22M | 2 | 0 | 0 | 0 | 2 |
| GILD | GILEAD SCIENCES INC | 9,278,290 | $694.93K | 0 | 7 | 1 | 0 | 8 |
| QSI | QUANTUM-SI INC | 8,650,078 | $56.27K | 0 | 1 | 0 | 0 | 1 |
| PFE | PFIZER INC | 7,572,274 | $10.31M | 1 | 5 | 5 | 0 | 13 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 6,823,390 | $410.02K | 0 | 2 | 2 | 1 | 4 |
| FMS | FRESENIUS MEDICAL CARE-ADR | 6,652,532 | $228.65K | 1 | 1 | 0 | 0 | 2 |
| NVS | NOVARTIS AG-SPONSORED ADR | 5,886,790 | $21.11K | 0 | 3 | 3 | 2 | 7 |
| PRCT | PROCEPT BIOROBOTICS CORP | 4,907,892 | $187.24K | 1 | 0 | 0 | 0 | 1 |
| RLYB | RALLYBIO CORP | 4,194,777 | $73.74K | 1 | 0 | 0 | 0 | 1 |
| FATE | FATE THERAPEUTICS INC | 3,834,437 | -$27.76K | 0 | 2 | 0 | 1 | 2 |
| CI | THE CIGNA GROUP | 3,365,786 | $97.78K | 0 | 3 | 2 | 0 | 5 |
| INCY | INCYTE CORP | 2,647,193 | -$142.40K | 0 | 1 | 3 | 0 | 4 |
| ELAN | ELANCO ANIMAL HEALTH INC | 2,626,019 | $71.22K | 1 | 0 | 3 | 0 | 4 |
| HUM | HUMANA INC | 2,503,189 | $941.45K | 1 | 2 | 0 | 0 | 3 |
| JNJ | JOHNSON & JOHNSON | 1,830,343 | $429.73K | 1 | 5 | 8 | 1 | 19 |
| AVIR | ATEA PHARMACEUTICALS INC | 1,677,687 | $58.82K | 2 | 0 | 0 | 0 | 2 |
| SENS | SENSEONICS HOLDINGS INC | 1,676,173 | $3.10K | 0 | 1 | 0 | 0 | 1 |
| ZLAB | ZAI LAB LTD-ADR | 1,649,899 | $63.67K | 1 | 1 | 0 | 0 | 2 |
| NUVL | NUVALENT INC-A | 1,647,671 | $37.16K | 1 | 0 | 0 | 0 | 1 |
| OSCR | OSCAR HEALTH INC - CLASS A | 1,450,858 | -$391 | 0 | 2 | 0 | 0 | 2 |
| THC | TENET HEALTHCARE CORP | 1,074,674 | $70.15K | 0 | 1 | 0 | 0 | 1 |
| BLRX | BIOLINERX LTD-SPONS ADR | 1,013,105 | $2.78K | 1 | 0 | 1 | 0 | 2 |
| EXAS | EXACT SCIENCES CORP | 1,001,839 | -$213.95K | 0 | 1 | 0 | 0 | 1 |
| LLY | ELI LILLY & CO | 949,325 | $220.65K | 0 | 1 | 3 | 0 | 5 |
| RPTX | REPARE THERAPEUTICS INC | 935,979 | $14.45K | 0 | 1 | 1 | 0 | 2 |
| AHCO | ADAPTHEALTH CORP | 910,796 | $8.18K | 0 | 1 | 0 | 1 | 1 |
| CARA | CARA THERAPEUTICS INC | 837,783 | $13.92K | 0 | 1 | 0 | 1 | 1 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 808,189 | -$42.66K | 0 | 3 | 0 | 0 | 4 |
| PPBT | PURPLE BIOTECH LTD-ADR | 736,019 | $3.37K | 1 | 0 | 0 | 0 | 1 |
| VERV | VERVE THERAPEUTICS INC | 719,316 | $26.54K | 0 | 1 | 0 | 0 | 1 |
| BAX | BAXTER INTERNATIONAL INC | 679,661 | $54.56K | 1 | 3 | 0 | 1 | 6 |
| GH | GUARDANT HEALTH INC | 638,573 | $83.32K | 0 | 1 | 0 | 0 | 2 |
| ILMN | ILLUMINA INC | 619,325 | $66.71K | 2 | 1 | 2 | 0 | 5 |
| DH | DEFINITIVE HEALTHCARE CORP | 600,000 | $25.70K | 1 | 0 | 0 | 0 | 1 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 584,861 | $19.22K | 1 | 6 | 1 | 2 | 8 |
| CLDX | CELLDEX THERAPEUTICS INC | 559,545 | $37.69K | 1 | 0 | 1 | 0 | 2 |
| UHS | UNIVERSAL HEALTH SERVICES-B | 546,643 | $50.76K | 0 | 1 | 0 | 0 | 2 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 489,444 | -$219.42K | 0 | 1 | 0 | 0 | 2 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 476,928 | $2.69K | 0 | 1 | 0 | 0 | 1 |
| DGX | QUEST DIAGNOSTICS INC | 471,498 | $141.26K | 0 | 1 | 1 | 1 | 3 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 465,105 | $8.94K | 1 | 0 | 0 | 0 | 1 |
| TDOC | TELADOC HEALTH INC | 441,551 | -$576.88K | 0 | 2 | 0 | 1 | 2 |
| ELV | ELEVANCE HEALTH INC | 428,412 | $75.33K | 2 | 3 | 4 | 1 | 10 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 420,930 | -$201.91K | 0 | 1 | 1 | 1 | 2 |
| OPCH | OPTION CARE HEALTH INC | 407,500 | $10.14K | 1 | 2 | 0 | 0 | 3 |
| TALK | TALKSPACE INC | 366,323 | $1.34K | 1 | 0 | 0 | 0 | 1 |
| BEAM | BEAM THERAPEUTICS INC | 363,855 | -$238.47K | 0 | 1 | 0 | 1 | 1 |
| MRVI | MARAVAI LIFESCIENCES HLDGS-A | 305,281 | $19.72K | 0 | 1 | 0 | 0 | 1 |
| DVA | DAVITA INC | 298,187 | -$116.23K | 0 | 1 | 0 | 0 | 2 |
Frequently asked questions about Most bought healthcare stocks in Q3 2021
What are the most bought Healthcare stocks in Q3 2021?
The most bought healthcare stocks in Q3 2021 are those with the largest increase in reported share counts across tracked institutional investors compared to Q2 2021, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q3 2021?
Among the managers we track, net additions were largest in companies such as SANOFI-ADR (SNY), WARBY PARKER INC-CLASS A (WRBY), GILEAD SCIENCES INC (GILD), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q2 2021).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.